$0.84 2.4%
Price vs. AI Score (Last 150 days)
Data gathered: December 6

Data Bits

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Karyopharm Therapeutics

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases.

Karyopharm Therapeutics
Price $0.84
Target Price Sign up
Market Cap $100M
Dividend Yield 0
Industry Biotechnology

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '2330M31M-870,000-35M-28M
Q2 '2332M34M-2.7M-33M-27M
Q1 '2333M36M-3M-34M-28M
Q4 '2228M35M-7M-39M-33M
Q3 '2230M35M-4.6M-36M-30M

Insider Transactions

Paulson Richard A. filed to sell 787,579 shares at $0.8.
December 5 '23
Paulson Richard A. filed to sell 791,201 shares at $0.9.
November 7 '23
Paulson Richard A. filed to sell 794,807 shares at $1.3.
October 5 '23
Paulson Richard A. filed to sell 798,396 shares at $1.3.
September 6 '23
Cheng Sohanya Roshan filed to sell 204,086 shares at $1.3.
September 5 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.